These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21051507)

  • 1. Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis.
    Levy M; Llinas RH
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):E1-2. PubMed ID: 21051507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot safety trial of deferiprone in 10 subjects with superficial siderosis.
    Levy M; Llinas R
    Stroke; 2012 Jan; 43(1):120-4. PubMed ID: 22034002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agranulocytosis with deferiprone treatment of superficial siderosis.
    Huprikar N; Gossweiler M; Callaghan M; Bunge P
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23925681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of superficial siderosis with iron chelation therapy.
    Cummins G; Crundwell G; Baguley D; Lennox G
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23843408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major.
    Musallam KM; Taher AT
    Haematologica; 2011 Feb; 96(2):e5-6; author reply e7-8. PubMed ID: 21282714
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment Response of Deferiprone in Infratentorial Superficial Siderosis: a Systematic Review.
    Flores Martin A; Shanmugarajah P; Hoggard N; Hadjivassiliou M
    Cerebellum; 2021 Jun; 20(3):454-461. PubMed ID: 33409768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative clinical and radiological recovery in post-operative patients with superficial siderosis by an iron chelator.
    Nose Y; Uwano I; Tateishi U; Sasaki M; Yokota T; Sanjo N
    J Neurol; 2022 May; 269(5):2539-2548. PubMed ID: 34664101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report.
    Schirinzi T; Sancesario G; Anemona L; Pisani A; Sancesario G
    Neurol Sci; 2014 Jul; 35(7):1151-2. PubMed ID: 24627229
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.
    Pennell DJ; Berdoukas V; Karagiorga M; Ladis V; Piga A; Aessopos A; Gotsis ED; Tanner MA; Smith GC; Westwood MA; Wonke B; Galanello R
    Blood; 2006 May; 107(9):3738-44. PubMed ID: 16352815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year observational study of deferiprone in superficial siderosis.
    Kessler RA; Li X; Schwartz K; Huang H; Mealy MA; Levy M
    CNS Neurosci Ther; 2018 Mar; 24(3):187-192. PubMed ID: 29285884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferiprone Reduces Hemosiderin Deposition in Superficial Siderosis.
    Kuo PH; Kuo SH; Lo RY
    Can J Neurol Sci; 2017 Mar; 44(2):219-220. PubMed ID: 27788692
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study.
    Cossu G; Abbruzzese G; Forni GL; Matta G; Pinto V; Ruffinengo U; Oppo V; Marchese R
    Neurol Sci; 2019 Jul; 40(7):1357-1361. PubMed ID: 30903420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial siderosis associated with multiple cavernous malformations: report of three cases.
    Li KW; Haroun RI; Clatterbuck RE; Murphy K; Rigamonti D
    Neurosurgery; 2001 May; 48(5):1147-50; discussion 1150-1. PubMed ID: 11334283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2*-weighted MRI findings of superficial siderosis.
    Yamamoto Y; Yamamoto S; Kuroki S
    Intern Med; 2012; 51(14):1949. PubMed ID: 22821124
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring and treatment of iron overload: state of the art and new approaches.
    Porter JB
    Semin Hematol; 2005 Apr; 42(2 Suppl 1):S14-8. PubMed ID: 15846580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Superficial siderosis in a patient with prolactinoma].
    Sato J
    No To Shinkei; 2003 Aug; 55(8):716-7. PubMed ID: 13677307
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease.
    Martin-Bastida A; Ward RJ; Newbould R; Piccini P; Sharp D; Kabba C; Patel MC; Spino M; Connelly J; Tricta F; Crichton RR; Dexter DT
    Sci Rep; 2017 May; 7(1):1398. PubMed ID: 28469157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Acute Superficial Siderosis Syndrome - Clinical Entity, Imaging Findings, and Histopathology.
    Friedauer L; Foerch C; Steinbach J; Hattingen E; Harter PN; Armbrust M; Urban H; Steidl E; Neuhaus E; von Brauchitsch S
    Cerebellum; 2023 Apr; 22(2):296-304. PubMed ID: 35316464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial siderosis: associations and therapeutic implications.
    Kumar N
    Arch Neurol; 2007 Apr; 64(4):491-6. PubMed ID: 17420310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningeal melanocytoma of the cerebellopontine angle as the unusual cause of superficial siderosis.
    Vreto G; Rroji A; Xhumari A; Leka L; Rakacolli M; Petrela M
    Neuroradiology; 2011 Nov; 53(11):927-30. PubMed ID: 21207224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.